HistoGeneX (Belgium)

HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

Helen Davies, Dominik Głodzik, Sandro Morganella et al. · Nature Medicine · 2017 · 1.1K citations · Full text

Genetic Disorder, Medicine, Genetics +8

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr, Mark Kockx et al. · Journal of Thoracic Oncology · 2018 · 793 citations · Full text

Real-life Clinical Samples, Biomarker (Medicine), Translational Medicine +12

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Thomas Powles, Mark Kockx, Alejo Rodríguez‐Vida et al. · Nature Medicine · 2019 · 555 citations · Full text

Urology, Biomarker Analysis, Genitourinary Cancer +7

Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques

Wim Martinet, Michiel Knaapen, Guido R.Y. De Meyer et al. · Circulation · 2002 · 442 citations